|
OMIM |
Link |
Information gain |
01 |
|
IDDM
|
[NCBI]
|
0.0714923
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.00929004
|
|
|
IDDM4
|
[NCBI]
|
0.0076987
|
|
|
IDDM7
|
[NCBI]
|
0.0038314
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
0.00319038
|
|
|
IDDM15
|
[NCBI]
|
0.0019113
|
|
|
IDDM3
|
[NCBI]
|
0.0019113
|
|
|
IDDM13
|
[NCBI]
|
0.0019113
|
|
|
IDDM18
|
[NCBI]
|
0.0019113
|
|
|
IDDM11
|
[NCBI]
|
0.0019113
|
|
|
CD
|
[NCBI]
|
0.00147158
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
0.0013456
|
|
|
MODY
|
[NCBI]
|
0.00133594
|
|
|
IDDM17
|
[NCBI]
|
0.00127323
|
|
|
IDDM8
|
[NCBI]
|
0.00127323
|
|
|
IDDM6
|
[NCBI]
|
0.00127323
|
|
|
WFS1
|
[NCBI]
|
0.000844604
|
|
|
CELIAC6
|
[NCBI]
|
0.000842807
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
0.000750771
|
|
|
G6PC2
|
[NCBI]
|
0.000744871
|
|
|
IDDM5
|
[NCBI]
|
0.00064922
|
|
|
INS
|
[NCBI]
|
0.000569922
|
|
|
GAD2
|
[NCBI]
|
0.000519193
|
|
|
pancreatic agenesis, congenital
|
[NCBI]
|
0.000483487
|
|
|
IDDM10
|
[NCBI]
|
0.000463451
|
|
|
IDDM12
|
[NCBI]
|
0.000463451
|
|
|
IPEX
|
[NCBI]
|
0.000353434
|
|
|
IAPP
|
[NCBI]
|
0.000291967
|
|
|
SUMO4
|
[NCBI]
|
0.00028766
|
|
|
TRMA
|
[NCBI]
|
0.00028668
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
0.000277905
|
|
|
HLA-DQA1
|
[NCBI]
|
0.000272769
|
|
|
microtia-anotia
|
[NCBI]
|
0.00025382
|
|
|
PTPRN
|
[NCBI]
|
0.000236599
|
|
|
APS1
|
[NCBI]
|
0.000189619
|
|
|
HLA-DQB1
|
[NCBI]
|
0.000188796
|
|
|
pancreatic hypoplasia, congenital, with diabetes mellitus and congenital heart disease
|
[NCBI]
|
0.000185215
|
|
|
PTPRN2
|
[NCBI]
|
0.000172846
|
|
|
EIF2AK3
|
[NCBI]
|
0.00016334
|
|
|
GIP
|
[NCBI]
|
0.000160744
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
0.000150231
|
|
|
TNFSF6
|
[NCBI]
|
0.000143473
|
|
|
GAD1
|
[NCBI]
|
0.000139383
|
|
|
CEACAM5
|
[NCBI]
|
0.000138856
|
|
|
ICA1
|
[NCBI]
|
0.000135703
|
|
|
NIDDM
|
[NCBI]
|
0.000134341
|
|
|
CTLA4
|
[NCBI]
|
0.000132093
|
|
|
APS2
|
[NCBI]
|
0.000125403
|
|
|
PTPN22
|
[NCBI]
|
0.000124786
|
|
|
INSR
|
[NCBI]
|
0.000117451
|
|
|
ACE
|
[NCBI]
|
0.000112899
|
|
|
CBLB
|
[NCBI]
|
0.000105328
|
|
|
SOD2
|
[NCBI]
|
0.000103791
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
9.8103e-05
|
|
|
PCNA
|
[NCBI]
|
9.70344e-05
|
|
|
MODY1
|
[NCBI]
|
9.53283e-05
|
|
|
HNF1A
|
[NCBI]
|
9.50694e-05
|
|
|
IL18
|
[NCBI]
|
9.35503e-05
|
|
|
PNDM
|
[NCBI]
|
9.27811e-05
|
|
|
IDDM19
|
[NCBI]
|
9.258e-05
|
|
|
diabetes mellitus, congenital autoimmune
|
[NCBI]
|
9.258e-05
|
|
|
atherosclerosis, premature, with deafness, nephropathy, diabetes mellitus, photomyoclonus, and degenerative neurologic disease
|
[NCBI]
|
9.258e-05
|
|
|
pancreas, dorsal, agenesis of
|
[NCBI]
|
9.258e-05
|
|
|
mental retardation syndrome, belgian type
|
[NCBI]
|
9.258e-05
|
|
|
glutamic acid decarboxylase, brain, membrane form
|
[NCBI]
|
9.258e-05
|
|
|
chondrodysplasia, lethal, with long bone angulation and mixed bone density
|
[NCBI]
|
9.258e-05
|
|
|
bird-headed dwarfism with progressive ataxia, insulin-resistant diabetes, goiter, and primary gonadal insufficiency
|
[NCBI]
|
9.258e-05
|
|
|
CTGF
|
[NCBI]
|
9.16003e-05
|
|
|
IRDN
|
[NCBI]
|
9.13803e-05
|
|
|
AKR1B1
|
[NCBI]
|
9.10637e-05
|
|
|
LPL
|
[NCBI]
|
9.04516e-05
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
9.04275e-05
|
|
|
CP
|
[NCBI]
|
8.89186e-05
|
|
|
aceruloplasminemia
|
[NCBI]
|
8.82406e-05
|
|
|
CLEC16A
|
[NCBI]
|
8.63959e-05
|
|
|
OAS1
|
[NCBI]
|
8.63959e-05
|
|
|
SLC11A1
|
[NCBI]
|
8.32366e-05
|
|
|
MPO
|
[NCBI]
|
7.94969e-05
|
|
|
KSS
|
[NCBI]
|
7.82856e-05
|
|
|
JK
|
[NCBI]
|
7.78664e-05
|
|
|
VDR
|
[NCBI]
|
7.77348e-05
|
|
|
LRP5
|
[NCBI]
|
7.32941e-05
|
|
|
TNF
|
[NCBI]
|
7.21162e-05
|
|
|
TPO
|
[NCBI]
|
7.02732e-05
|
|
|
pancreatic beta cell agenesis with neonatal diabetes mellitus
|
[NCBI]
|
7.01609e-05
|
|
|
PLTP
|
[NCBI]
|
6.98863e-05
|
|
|
TAP1
|
[NCBI]
|
6.75631e-05
|
|
|
CD3E
|
[NCBI]
|
6.75631e-05
|
|
|
KCNJ11
|
[NCBI]
|
6.558e-05
|
|
|
MICA
|
[NCBI]
|
6.44813e-05
|
|
|
graves disease
|
[NCBI]
|
6.36213e-05
|
|
|
CELIAC3
|
[NCBI]
|
6.17324e-05
|
|
|
alaninuria with microcephaly, dwarfism, enamel hypoplasia, and diabetes mellitus
|
[NCBI]
|
6.17324e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
6.17324e-05
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
6.17324e-05
|
|
|
MTTE
|
[NCBI]
|
6.0907e-05
|
|
|
PLAGL1
|
[NCBI]
|
5.82859e-05
|
|
|
ALB
|
[NCBI]
|
5.53044e-05
|
|
|
AIRE
|
[NCBI]
|
5.48246e-05
|
|
|
IGAD1
|
[NCBI]
|
5.46997e-05
|
|
|
PTH
|
[NCBI]
|
5.29612e-05
|
|
|
C11ORF24
|
[NCBI]
|
5.26574e-05
|
|
|
PRSS16
|
[NCBI]
|
5.26574e-05
|
|
|
PSMB8
|
[NCBI]
|
5.26574e-05
|
|
|
SAPS3
|
[NCBI]
|
5.26574e-05
|
|
|
SUV420H1
|
[NCBI]
|
5.26574e-05
|
|
|
SOX13
|
[NCBI]
|
5.26574e-05
|
|
|
PSMB9
|
[NCBI]
|
5.26574e-05
|
|
|
GAD3
|
[NCBI]
|
5.26574e-05
|
|
|
ramon syndrome
|
[NCBI]
|
4.90249e-05
|
|
|
HLA-DRA
|
[NCBI]
|
4.88499e-05
|
|
|
FOXP3
|
[NCBI]
|
4.81109e-05
|
|
|
CPAF
|
[NCBI]
|
4.40941e-05
|
|
|
IBMPFD
|
[NCBI]
|
4.40941e-05
|
|
|
IL2RA
|
[NCBI]
|
4.26196e-05
|
|
|
NOS2A
|
[NCBI]
|
4.26196e-05
|
|
|
CAT
|
[NCBI]
|
4.25183e-05
|
|
|
ABCC8
|
[NCBI]
|
4.15411e-05
|
|
|
GFAP
|
[NCBI]
|
4.04882e-05
|
|
|
MODY3
|
[NCBI]
|
4.03648e-05
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
3.8961e-05
|
|
|
RBM17
|
[NCBI]
|
3.89265e-05
|
|
|
SH2B3
|
[NCBI]
|
3.89265e-05
|
|
|
ITPR3
|
[NCBI]
|
3.89265e-05
|
|
|
E2F2
|
[NCBI]
|
3.89265e-05
|
|
|
ECE2
|
[NCBI]
|
3.89265e-05
|
|
|
PECI
|
[NCBI]
|
3.89265e-05
|
|
|
PTPN2
|
[NCBI]
|
3.89265e-05
|
|
|
SEL1L
|
[NCBI]
|
3.89265e-05
|
|
|
TBP
|
[NCBI]
|
3.88258e-05
|
|
|
IL12B
|
[NCBI]
|
3.71943e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
3.60738e-05
|
|
|
CF
|
[NCBI]
|
3.60672e-05
|
|
|
GCK
|
[NCBI]
|
3.43401e-05
|
|
|
CCR7
|
[NCBI]
|
3.37749e-05
|
|
|
PDCD2
|
[NCBI]
|
3.37749e-05
|
|
|
TAP2
|
[NCBI]
|
3.37749e-05
|
|
|
PAX4
|
[NCBI]
|
3.37749e-05
|
|
|
AIF1
|
[NCBI]
|
3.37749e-05
|
|
|
APOE
|
[NCBI]
|
3.25801e-05
|
|
|
IGF1
|
[NCBI]
|
3.18706e-05
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
3.1786e-05
|
|
|
autoimmune disease
|
[NCBI]
|
3.1786e-05
|
|
|
PCK1
|
[NCBI]
|
3.04469e-05
|
|
|
NEUROG3
|
[NCBI]
|
3.04469e-05
|
|
|
EHF
|
[NCBI]
|
3.04469e-05
|
|
|
IFIH1
|
[NCBI]
|
3.04469e-05
|
|
|
SLC2A2
|
[NCBI]
|
2.97274e-05
|
|
|
CFTR
|
[NCBI]
|
2.83089e-05
|
|
|
TNFRSF8
|
[NCBI]
|
2.7985e-05
|
|
|
GLO1
|
[NCBI]
|
2.7985e-05
|
|
|
CYR61
|
[NCBI]
|
2.7985e-05
|
|
|
MAP4
|
[NCBI]
|
2.7985e-05
|
|
|
P4HB
|
[NCBI]
|
2.7985e-05
|
|
|
LRP6
|
[NCBI]
|
2.7985e-05
|
|
|
AMY1A
|
[NCBI]
|
2.7985e-05
|
|
|
CPB1
|
[NCBI]
|
2.7985e-05
|
|
|
ALOX12
|
[NCBI]
|
2.7985e-05
|
|
|
NR4A1
|
[NCBI]
|
2.7985e-05
|
|
|
CCK
|
[NCBI]
|
2.76502e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
2.7079e-05
|
|
|
NPPA
|
[NCBI]
|
2.66213e-05
|
|
|
pancreatic carcinoma
|
[NCBI]
|
2.64276e-05
|
|
|
JBS
|
[NCBI]
|
2.64276e-05
|
|
|
IL2
|
[NCBI]
|
2.61091e-05
|
|
|
TLR1
|
[NCBI]
|
2.60332e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
2.60332e-05
|
|
|
ERBB3
|
[NCBI]
|
2.60332e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
2.58056e-05
|
|
|
ALMS
|
[NCBI]
|
2.46407e-05
|
|
|
neural tube defects
|
[NCBI]
|
2.46407e-05
|
|
|
CXCR3
|
[NCBI]
|
2.44186e-05
|
|
|
CXCL10
|
[NCBI]
|
2.44186e-05
|
|
|
NEUROD1
|
[NCBI]
|
2.44186e-05
|
|
|
CGL2
|
[NCBI]
|
2.35684e-05
|
|
|
PRPH
|
[NCBI]
|
2.30434e-05
|
|
|
ECE1
|
[NCBI]
|
2.30434e-05
|
|
|
AGER
|
[NCBI]
|
2.22756e-05
|
|
|
REG3A
|
[NCBI]
|
2.22462e-05
|
|
|
NRCLP1
|
[NCBI]
|
2.12162e-05
|
|
|
ACHE
|
[NCBI]
|
2.11491e-05
|
|
|
IDE
|
[NCBI]
|
2.10495e-05
|
|
|
LCAT
|
[NCBI]
|
2.10442e-05
|
|
|
PGM1
|
[NCBI]
|
2.07905e-05
|
|
|
RBP3
|
[NCBI]
|
2.07905e-05
|
|
|
LCK
|
[NCBI]
|
2.07905e-05
|
|
|
SLC19A2
|
[NCBI]
|
2.07905e-05
|
|
|
PWS
|
[NCBI]
|
2.02311e-05
|
|
|
MBL2
|
[NCBI]
|
2.02052e-05
|
|
|
PTGS1
|
[NCBI]
|
1.98446e-05
|
|
|
EGF
|
[NCBI]
|
1.96677e-05
|
|
|
LAT
|
[NCBI]
|
1.89895e-05
|
|
|
MAFD1
|
[NCBI]
|
1.8254e-05
|
|
|
CD8A
|
[NCBI]
|
1.821e-05
|
|
|
E2F1
|
[NCBI]
|
1.821e-05
|
|
|
SHBG
|
[NCBI]
|
1.79379e-05
|
|
|
LEPR
|
[NCBI]
|
1.75132e-05
|
|
|
PI
|
[NCBI]
|
1.73756e-05
|
|
|
NR4A2
|
[NCBI]
|
1.68337e-05
|
|
|
CRH
|
[NCBI]
|
1.6082e-05
|
|
|
TFPI
|
[NCBI]
|
1.57645e-05
|
|
|
ADHD
|
[NCBI]
|
1.57454e-05
|
|
|
IPF1
|
[NCBI]
|
1.56485e-05
|
|
|
IGKC
|
[NCBI]
|
1.56485e-05
|
|
|
ADRB3
|
[NCBI]
|
1.56485e-05
|
|
|
SLE
|
[NCBI]
|
1.55449e-05
|
|
|
IL4R
|
[NCBI]
|
1.51132e-05
|
|
|
NR4A3
|
[NCBI]
|
1.51132e-05
|
|
|
CETP
|
[NCBI]
|
1.51132e-05
|
|
|
CTNS
|
[NCBI]
|
1.47003e-05
|
|
|
C4B
|
[NCBI]
|
1.46106e-05
|
|
|
TNFRSF6B
|
[NCBI]
|
1.4137e-05
|
|
|
DDIT3
|
[NCBI]
|
1.4137e-05
|
|
|
CHGA
|
[NCBI]
|
1.4137e-05
|
|
|
CTSL
|
[NCBI]
|
1.32659e-05
|
|
|
CEL
|
[NCBI]
|
1.32659e-05
|
|
|
PYY
|
[NCBI]
|
1.31746e-05
|
|
|
HNF1B
|
[NCBI]
|
1.28638e-05
|
|
|
WFS1
|
[NCBI]
|
1.28638e-05
|
|
|
NR0B2
|
[NCBI]
|
1.28638e-05
|
|
|
FABP2
|
[NCBI]
|
1.24813e-05
|
|
|
CCL21
|
[NCBI]
|
1.24813e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.1769e-05
|
|
|
SLC18A2
|
[NCBI]
|
1.1769e-05
|
|
|
MAPK1
|
[NCBI]
|
1.1769e-05
|
|
|
HNF4A
|
[NCBI]
|
1.1769e-05
|
|
|
CD40LG
|
[NCBI]
|
1.1769e-05
|
|
|
TH
|
[NCBI]
|
1.14183e-05
|
|
|
DYT1
|
[NCBI]
|
1.1118e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.1118e-05
|
|
|
PAI1
|
[NCBI]
|
1.1118e-05
|
|
|
ABP1
|
[NCBI]
|
1.08187e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.0772e-05
|
|
|
HGF
|
[NCBI]
|
1.0633e-05
|
|
|
TLR3
|
[NCBI]
|
1.05198e-05
|
|
|
PF4
|
[NCBI]
|
1.04416e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.03133e-05
|
|
|
BLM
|
[NCBI]
|
1.02974e-05
|
|
|
SST
|
[NCBI]
|
1.00891e-05
|
|
|
HRG
|
[NCBI]
|
9.96734e-06
|
|
|
THPO
|
[NCBI]
|
9.96734e-06
|
|
|
MTTK
|
[NCBI]
|
9.70651e-06
|
|
|
IL13
|
[NCBI]
|
9.70651e-06
|
|
|
AVP
|
[NCBI]
|
9.64942e-06
|
|
|
SPP1
|
[NCBI]
|
9.56389e-06
|
|
|
GC
|
[NCBI]
|
9.45509e-06
|
|
|
HBB
|
[NCBI]
|
9.39478e-06
|
|
|
ADIPOQ
|
[NCBI]
|
9.21254e-06
|
|
|
IRS1
|
[NCBI]
|
9.21254e-06
|
|
|
TNFRSF6
|
[NCBI]
|
9.21254e-06
|
|
|
TLR2
|
[NCBI]
|
8.8794e-06
|
|
|
HBA1
|
[NCBI]
|
8.57529e-06
|
|
|
JAK3
|
[NCBI]
|
8.32145e-06
|
|
|
SDS
|
[NCBI]
|
8.1651e-06
|
|
|
VCP
|
[NCBI]
|
8.1164e-06
|
|
|
DCC
|
[NCBI]
|
7.91772e-06
|
|
|
autism
|
[NCBI]
|
7.8576e-06
|
|
|
RP
|
[NCBI]
|
7.24634e-06
|
|
|
SDC2
|
[NCBI]
|
7.1141e-06
|
|
|
HMI
|
[NCBI]
|
7.0098e-06
|
|
|
APOB
|
[NCBI]
|
6.79023e-06
|
|
|
F2
|
[NCBI]
|
6.6819e-06
|
|
|
MMP9
|
[NCBI]
|
6.6819e-06
|
|
|
FGF2
|
[NCBI]
|
6.07762e-06
|
|
|
NPY
|
[NCBI]
|
5.8245e-06
|
|
|
TGFB1
|
[NCBI]
|
5.79861e-06
|
|
|
CCL22
|
[NCBI]
|
5.66439e-06
|
|
|
VEGF
|
[NCBI]
|
5.62006e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
5.58433e-06
|
|
|
B2M
|
[NCBI]
|
5.40586e-06
|
|
|
PRL
|
[NCBI]
|
5.24141e-06
|
|
|
PAX6
|
[NCBI]
|
5.15979e-06
|
|
|
IL4
|
[NCBI]
|
5.15979e-06
|
|
|
KITLG
|
[NCBI]
|
4.81226e-06
|
|
|
G6PD
|
[NCBI]
|
4.73261e-06
|
|
|
BBS
|
[NCBI]
|
4.59574e-06
|
|
|
CCL17
|
[NCBI]
|
4.59388e-06
|
|
|
PTGS2
|
[NCBI]
|
4.48842e-06
|
|
|
IL10
|
[NCBI]
|
4.48842e-06
|
|
|
GAPDH
|
[NCBI]
|
4.46499e-06
|
|
|
CPB2
|
[NCBI]
|
4.28461e-06
|
|
|
RA
|
[NCBI]
|
4.28074e-06
|
|
|
ADA
|
[NCBI]
|
4.02371e-06
|
|
|
SLC2A4
|
[NCBI]
|
3.81332e-06
|
|
|
VIP
|
[NCBI]
|
3.76206e-06
|
|
|
AFP
|
[NCBI]
|
3.40248e-06
|
|
|
IGFALS
|
[NCBI]
|
3.15802e-06
|
|
|
MTTL1
|
[NCBI]
|
3.08364e-06
|
|
|
EIG
|
[NCBI]
|
2.93262e-06
|
|
|
PPARG
|
[NCBI]
|
2.86956e-06
|
|
|
GHRH
|
[NCBI]
|
2.82556e-06
|
|
|
ACP5
|
[NCBI]
|
2.76737e-06
|
|
|
TG
|
[NCBI]
|
2.67562e-06
|
|
|
LDLR
|
[NCBI]
|
2.59452e-06
|
|
|
TF
|
[NCBI]
|
2.55172e-06
|
|
|
ACADM
|
[NCBI]
|
2.54085e-06
|
|
|
COMT
|
[NCBI]
|
2.4111e-06
|
|
|
FRAP1
|
[NCBI]
|
2.38452e-06
|
|
|
TNC
|
[NCBI]
|
2.24393e-06
|
|
|
BTK
|
[NCBI]
|
2.13331e-06
|
|
|
PON1
|
[NCBI]
|
1.82691e-06
|
|
|
DGS
|
[NCBI]
|
1.77274e-06
|
|
|
GNRH1
|
[NCBI]
|
1.7073e-06
|
|
|
CDK4
|
[NCBI]
|
1.35284e-06
|
|
|
SPS
|
[NCBI]
|
1.32213e-06
|
|
|
EPO
|
[NCBI]
|
1.20654e-06
|
|
|
KCNH2
|
[NCBI]
|
1.2051e-06
|
|
|
BGLAP
|
[NCBI]
|
1.00523e-06
|
|
|
IL6
|
[NCBI]
|
9.44037e-07
|
|
|
HDC
|
[NCBI]
|
8.85407e-07
|
|
|
IFNA1
|
[NCBI]
|
8.29263e-07
|
|
|
polycystic kidneys
|
[NCBI]
|
5.15761e-07
|
|
|
PDCD8
|
[NCBI]
|
4.80233e-07
|
|
|
POMC
|
[NCBI]
|
3.96579e-07
|
|
|
CVID
|
[NCBI]
|
1.40384e-07
|
|
|
NGFB
|
[NCBI]
|
1.17016e-07
|
|
|
MDD
|
[NCBI]
|
1.11193e-07
|
|
|
phenylketonuria
|
[NCBI]
|
7.45403e-08
|
|
|
PPARA
|
[NCBI]
|
6.98627e-08
|
|
|
TNFSF10
|
[NCBI]
|
6.36368e-08
|
|
|
MG
|
[NCBI]
|
3.38785e-08
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.14873e-08
|
|
|
TTR
|
[NCBI]
|
1.36949e-08
|
|
|
F3
|
[NCBI]
|
8.86523e-09
|
|
|
HFE
|
[NCBI]
|
6.65699e-09
|
|
|
BRCA1
|
[NCBI]
|
2.36412e-09
|
|